It was reported by Chang et al. that a high detection rate of tumor surpressor genes such as RASSF1A could be evaluated in peripheral blood, mouth and throat rinsing fluid and nasopharyngeal swabs of NPC patients, indicating the potential role of epigenetic events in non-invasive screening of NPC[38]. This evidence concerns the gene RASSF1 and nasopharyngeal carcinoma.